Synairgen plc (LON:SNG – Get Rating) shares crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 19.03 ($0.23) and traded as low as GBX 17.28 ($0.20). Synairgen shares last traded at GBX 18.50 ($0.22), with a volume of 324,019 shares.
Synairgen Trading Up 0.7 %
The firm has a fifty day moving average of GBX 19.03 and a two-hundred day moving average of GBX 24.08. The company has a current ratio of 6.35, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09. The company has a market cap of £37.24 million and a PE ratio of -0.76.
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Ardelyx is A Buy After Slip in Early 2022
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.